Alto Neuroscience, Inc. (ANRO)
NYSE·Healthcare·Biotechnology
$24.39
+0.47%
Mkt Cap $783.30M
Next Earnings
In 14 daysWed, May 13, 2026
EPS Estimate
-$0.56
3 analysts
Revenue Estimate
$0
Last quarter: beat by +19.64% on EPS.
EPS — Estimate vs Actual
Mkt Cap
$783.30M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.24